mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges

By Zhilin Zou, Tao Tao, Hongmei Li, Xiao Zhu. Cell & Bioscience, 2020

792 citations recorded by the source corpus.

Mammalian target of rapamycin (mTOR) regulates cell proliferation, autophagy, and apoptosis by participating in multiple signaling pathways in the body. Studies have shown that the mTOR signaling pathway is also associated with cancer, arthritis, insulin resistance, osteoporosis, and other diseases. The mTOR signaling pathway, which is often activated in tumors, not only regulates gene transcription and protein synthesis to regulate cell proliferation and immune cell differentiation but also plays an important role in tumor metabolism. Therefore, the mTOR signaling pathway is a hot target in anti-tumor therapy research. In recent years, a variety of newly discovered mTOR inhibitors have entered clinical studies, and a variety of drugs have been proven to have high activity in combination with mTOR inhibitors. The purpose of this review is to introduce the role of mTOR signaling pathway on apoptosis, autophagy, growth, and metabolism of tumor cells, and to introduce the research progress of mTOR inhibitors in the tumor field.

Subfields: Epidemiology, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/1716922cf939f688e6f5d5dae0f462c7daa23c53

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

Citations in the corpus

Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease (2023, background): “5 Moreover, mTOR signaling plays a vital role in enabling T cells to perceive and merge immune signals originating from dendritic cells (DCs).”